
New studies at the University of Pennsylvania and University of Washington aim to examine whether GLP-1 drugs like Ozempic or Wegovy could affect people’s gambling habits. Pennsylvania will use MRI scans to examine the brain’s reward systems while Washington will survey gambling urges and impulse control. This builds on anecdotal evidence these drugs could help fight gambling addiction with over 10% of the US population taking GLP-1 drugs.
SCCG Take — Positive findings could broaden options for addressing gambling harm. Reliance on established professional treatment remains essential pending validation.
New studies are underway to assess whether GLP-1 drugs including Ozempic and Wegovy might assist in reducing gambling addiction. These efforts follow mounting anecdotal reports of craving suppression that could extend beyond food. The work represents some of the first formal examinations of broader neurological effects.
The Wharton School of the University of Pennsylvania will conduct a study utilizing MRI scans to monitor modifications in the brain’s reward systems. Participants will undertake financial decision-making tasks to evaluate changes in how they view risk and perceive value.
Michael Platt, professor at the University of Pennsylvania, stated that the investigation may show if these drugs suppress temptations including gambling.
“We believe GLP-1s will lead to some structural remodeling of the brain, which is where some of those long-term impacts on food choice could show up, but also on financial decision-making.”
The University of Washington is pursuing a complementary approach. Researchers will interview individuals taking the medications who engage in gambling. The discussions will cover gambling urges, impulse control, and associated behaviors to test if food craving suppression applies more broadly.
Anecdotal evidence has accumulated, such as a 2023 Reddit post in which an individual reported that Ozempic helped them view gambling as “stupid.” The same user noted reduced Adderall consumption and called the drug’s effect “almost like a literal miracle.”
With over 10% of the US population using GLP-1 drugs, according to GamblingNews, any confirmed effect on addictions could transform treatment and prevention strategies. Yet the connection remains unproven.
Those facing gambling-related harm should utilize traditional help lines with trained professionals. Medical consultation is critical before using these prescriptions for unapproved purposes due to potential unexpected long-term effects.
These studies mark initial formal efforts to explore the neurological impacts beyond weight loss. Future results will clarify whether the observed patterns hold under controlled examination and what role, if any, these medications might play alongside existing resources.
Gaming, betting and prediction markets — the desk’s read, every weekday.
Subscribe →